SANDOZ PENTASONE 3 MG
GENTAMICIN (GENTAMICIN SULFATE) : 3 MG BETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE) : 1 MG · DIN 02244999 · SANDOZ CANADA INCORPORATED
Health Canada status: CANCELLED POST MARKET
What is SANDOZ PENTASONE?
SANDOZ PENTASONE 3 MG contains GENTAMICIN (GENTAMICIN SULFATE) : 3 MG BETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE) : 1 MG. It is listed in the Health Canada Drug Product Database under DIN 02244999, held by SANDOZ CANADA INCORPORATED, supplied as SOLUTION for OTIC ; OPHTHALMIC administration. Health Canada currently lists it as cancelled post market, status dated 01-Aug-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02244999 |
|---|---|
| Brand name | SANDOZ PENTASONE |
| Generic / active ingredient | GENTAMICIN (GENTAMICIN SULFATE) : 3 MG BETAMETHASONE (BETAMETHASONE SODIUM PHOSPHATE) : 1 MG |
| Manufacturer | SANDOZ CANADA INCORPORATED |
| Strength | 3 MG |
| Dosage form | SOLUTION |
| Route of administration | OTIC ; OPHTHALMIC |
| Schedule | Prescription |
| ATC code | S03CA06 BETAMETHASONE AND ANTIINFECTIVES |
| AHFS class | 56:28.12 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 01-Aug-2017 |
| Original market date | 2003-11-17 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code S03CA06 BETAMETHASONE AND ANTIINFECTIVES. 0 of 5 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| BETAMYCIN OPHTHALMIC/OTIC SOLUTION | 3 MG | SOLUTION | STERIMAX INC | CANCELLED PRE MARKET | DIN 02247446 |
| DOM-GENTAMICIN-BETAMETHASONE | 1 MG | LIQUID | DOMINION PHARMACAL | CANCELLED PRE MARKET | DIN 02238818 |
| GARASONE OPHTHALMIC AND OTIC SOLUTION | 3 MG | SOLUTION | MERCK CANADA INC | CANCELLED POST MARKET | DIN 00682217 |
| PMS-GENTAMICIN-BETAMETHASONE | 3 MG | LIQUID | PHARMASCIENCE INC | CANCELLED PRE MARKET | DIN 02238819 |
Who else supplies BETAMETHASONE AND ANTIINFECTIVES worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. BETAMETHASONE AND ANTIINFECTIVES appears in 2437 registered pack listings across 12 markets, published on 10 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.